Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
In the latest quarter, 11 analysts provided ratings for FMC (NYSE:FMC), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 3 | 6 | 1 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 1 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 0 | 2 | 4 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $64.36, a high estimate of $84.00, and a low estimate of $55.00. This upward trend is evident, with the current average reflecting a 0.25% increase from the previous average price target of $64.20.
An in-depth analysis of recent analyst actions unveils how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Aleksey Yefremov | Keybanc | Raises | Overweight | $79.00 | $76.00 |
Joshua Spector | UBS | Raises | Buy | $84.00 | $61.00 |
Christopher Kapsch | Loop Capital | Raises | Hold | $65.00 | $55.00 |
Christopher Kapsch | Loop Capital | Lowers | Hold | $55.00 | $68.00 |
Arun Viswanathan | RBC Capital | Lowers | Outperform | $59.00 | $61.00 |
Joel Jackson | BMO Capital | Lowers | Market Perform | $61.00 | $63.00 |
Laurent Favre | Exane BNP Paribas | Announces | Neutral | $56.00 | - |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $76.00 | $80.00 |
Christopher Parkinson | Mizuho | Lowers | Neutral | $55.00 | $59.00 |
Steve Byrne | B of A Securities | Lowers | Underperform | $57.00 | $60.00 |
Joshua Spector | UBS | Raises | Neutral | $61.00 | $59.00 |
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of FMC's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on FMC analyst ratings.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FMC's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -29.34%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: FMC's net margin is impressive, surpassing industry averages. With a net margin of 95.58%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): FMC's ROE excels beyond industry benchmarks, reaching 28.45%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.57% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.93, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: FMC